Last updated: 2026-10-12 22:03:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Edwards Lifesciences Corp. (EW) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $86,36, with a market capitalization of $49,12B and a P/E ratio of 48,88. Over the past 52 weeks, its price has ranged from $72,30 to $96,29. This page covers its latest market performance, valuation, price trends and company information.
$49,12B | |
$85,24 | |
$131,73 | |
$2,23 | |
$85,21 | |
2,60M | |
3,85M | |
48,88 | |
$96,29 | |
$72,30 | |
-- | |
-- |
Edwards Lifesciences Corp. (EW) is trading at $86,23 in after-hours trading as of 2026-10-12 21:50:00, up 1,19% ($1,02) from the regular-session close of $85,21.
After-hours trading shows how investors are pricing EW after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Edwards Lifesciences Corp. (EW) moved from $85,19 to $86,36, representing a gain of 1,38% ($1,17).
The stock traded between $82,43 and $87,88 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 3,73 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 58,6%
EW is currently trading at $86,36, placing it 58,6% of the way from its 52-week low of $72,30 to its 52-week high of $96,29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 16000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Edwards Lifesciences Corp. (EW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.